Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 19:10 | 5/17/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Gillies Hunter | MA | O | CHIEF ME | 14 | S.dm | -1,415 | 22.72 | 0 | -62 | 6 | D | |||||||||||||||
5/17/24 19:10 | 5/16/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Noyes Timothy P | MA | DO | CEO | 11 | S.dm | -2,498 | 22.08 | 0 | -113 | -100 | 0 | D | ||||||||||||||
5/3/24 18:00 | 5/2/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Verwijs Marinus | MA | O | CHIEF TE | 5 | S.d | -360 | 25.19 | 0 | -14 | -100 | 0 | D | ||||||||||||||
4/19/24 18:00 | 4/17/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Dake Benjamin T | MA | O | SEE REMA | 16 | S.dm | -3,629 | 20.99 | 0 | -173 | 1 | D | |||||||||||||||
4/12/24 18:00 | 4/10/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Eldridge George A | MA | O | SEE REMA | 4 | S.dm | -1,343 | 26.86 | 0 | -50 | 2 | D | |||||||||||||||
4/11/24 18:00 | 4/9/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Grayzel David S. | MA | D | 1 | S | -334 | 28.15 | 0 | -12 | 1,799 | I | ||||||||||||||||
2/7/24 18:00 | 2/5/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Niven Ralph | MA | O | CHIEF SC | 10 | S.d | -722 | 17.56 | 0 | -41 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |